• 1
    Okamura T, Kodama Y, Komegawa T, Sano C, Kumashiro R, Inokuchi K. Gastric carcinoma with lymphoid stroma: Correlation to reactive hyperplasia in regional lymph nodes and prognosis. Jpn J Surg. 1983;13: 177183.
  • 2
    Menard S, Tomasic G, Casalini P, et al. Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res. 1997;3: 817819.
  • 3
    Songun I, van de Velde CJ, Hermans J, et al. Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG). Br J Cancer. 1996;74: 17831788
  • 4
    Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology. 1986;10: 437459.
  • 5
    Rosenberg AS. Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens. J Nat Cancer Inst. 1996;88: 16351644.
  • 6
    de Gruijl TD, Bontkes HJ, Peccatori F, et al. Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes. Br J Cancer. 1999;79: 11271132.
  • 7
    Reichert TE, Day R, Wagner EM, Whiteside TL. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res. 1998;58: 53445347.
  • 8
    Ashwell JD, Klausner RD. Genetic and mutational analysis of the T-cell antigen receptor. Ann Rev Immunol. 1990;8: 139168.
  • 9
    Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochosa AC. Alternations in signal transduction molecules in T lymphocytes from tumor bearing mice. Science. 1992;258: 17951798.
  • 10
    Agrawal S, Marquet J, Delfau-Larue MH, et al. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs . J Clin Invest. 1998;102: 17151723.
  • 11
    Tartour E, Latour S, Mathiot C, et al. Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL. derived from renal-cell carcinoma: relationship with TIL phenotype and function . Int J Cancer. 1995;63: 205212.
  • 12
    Kono K, Ressing ME, Brandt RM, et al. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer . Clin Cancer Res. 1996;2: 18251828.
  • 13
    Mulder WM, Bloemena E, Stukart MJ, et al. T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut. 1997;40: 113119.
  • 14
    Kim CW, Choi SH, Chung EJ, et al. Alternation of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients. Pathobiology. 1999;67: 123128.
  • 15
    Kono K, Ichihara F, Iizuka H, Sekikawa T, Matsumoto Y. Expression of signal transducing T-cell zeta molecules after adoptive immunotherapy in patients with gastric and colon cancer. Int J Cancer. 1998;78: 301305.
  • 16
    Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 2nd English ed-. Gastric Cancer. 1998;1: 1024.
  • 17
    Torsten ER, Roger D, Wanger EM, Whiteside TL. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res. 1998;58: 53445347.
  • 18
    Kawakami Y, Robbins PF, Wang X, et al. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. J Immunol. 1998;161: 69856992.
  • 19
    Kono K, Rongcun Y, Charo J, et al. Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes. Int J Cancer. 1998;78: 202208.
  • 20
    Kawakami Y, Dang N, Wang X, et al. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. J Immunother. 2000;23: 1727.
  • 21
    Nakagomi H, Petersson M, Magnusson I, et al. Decreased expression of the signal-transduction zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res. 1993;53: 56105612.
  • 22
    Otsuji M, Kimura Y, Aoe T, Okamoto Y, Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci USA 1996; 93: 1311913124.
  • 23
    Kono K, Salazar-Onfray F, Petersson M, et al. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur J Immunol. 1996;26: 13081313
  • 24
    Zea AH, Brendan CD, Longo DL, et al. Alternation in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res. 1995;1: 13271335.
  • 25
    Rabinowich H, Reichert TE, Kashii Y, Gastman BR, Bell MC, Whiteside TL. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest. 1998;101: 25792588.
  • 26
    Whiteside TL. Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defects. Adv Exp Med Biol. 1998;451: 167171.